Moderna CEO Says Data for Omicron-Specific Shot Likely Available in March

Moderna CEO Says Data for Omicron-Specific Shot Likely Available in March
Nurse Ellen Quinones prepares a dose of the Moderna's coronavirus disease (COVID-19) vaccine at the Bathgate Post Office vaccination facility in the Bronx, N.Y., on Jan. 10, 2021. Kevin Hagen/Pool via Reuters
|Updated:

Moderna Inc.’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.

“The vaccine is being finished ... it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps,” Bancel said at the World Economic Forum’s virtual Davos Agenda conference.